BioSpace News Archive

Drug Development

Biohaven’s Manic Monday: FDA Accepts Migraine Treatment NDA, SCA Trial Disappoints

Biohaven Pharma’s NDA for its nasal spray zavegepant was accepted by the FDA, while Phase III results for its drug troriluzole to treat spinocerebellar ataxia were disappointing.

May 23, 2022
·
3 min read
·
Hannah Chudleigh
Business

Innoviva Snaps Up Remaining Entasis Shares, High Potential Assets

Burlingame, CA-based Innoviva is buying all of Waltham, MA-based Entasis Therapeutics’ available shares at $2.20 per share. Currently, Innoviva owns about 60% of Entasis’ outstanding shares.

May 23, 2022
·
3 min read
·
Mark Terry
Drug Development

Cytokinetics, Seagen, Concert and Idorsia Begin Week with Trial Wins

Several biopharma companies are opening the week with positive clinical trial news. Read on for updates from Cytokinetics, Concert Pharmaceuticals, Idorsia and Seagen.

May 23, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

ASCO, ACCC Join Forces to Increase Diversity in Cancer Clinical Trials

The American Society of Clinical Oncology and the Association of Community Cancer Centers are combining their efforts to increase racial and ethnic diversity in clinical trials.

May 23, 2022
·
6 min read
·
Geoff Herman
Deals

Kala Announces Entry into Definitive Agreement to Sell EYSUVIS® and INVELTYS® to Alcon Inc.

Kala Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to sell its commercial portfolio and related intellectual property assets to Alcon Inc.

May 23, 2022
·
10 min read
Deals

Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio

Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced it has signed an agreement to acquire EYSUVIS® 0.25% pharmaceutical eye drops from Kala Pharmaceuticals, Inc.

May 23, 2022
·
8 min read
Deals

Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market

Plandai Biotechnology Inc. announced its entry into a non-binding letter of intent to enter into a new business through a proposed product and technology rights licensing agreement with the holder of rights to the unique Puriblood Leukocyte Reduction Blood Filtration System.

May 23, 2022
·
5 min read
Leukotriene Inhibitors Market: Increase in Prevalence of Allergic Diseases to Drive the Market

Albany NY, United States: Allergy is a harmful immune response by the body to substances such as pollens, specific food, and dust, which are responsible for hypersensitivity.

May 23, 2022
·
5 min read
Insulin Delivery Pens Market Key Opportunities and Forecast Up to 2030

Albany NY, United States: People suffering from diabetes make use of insulin pens to administer insulin in their bodies.

May 23, 2022
·
5 min read
Hysteroscopy Device Market: Increasing Female Geriatric Population to Drive the Market

Albany NY, United States: Hysteroscopy is a simple procedure performed by doctors and gynecologists to investigate or look into the uterus of a woman with the help of a device called hysteroscope.

May 23, 2022
·
5 min read